Loading stock data…
GoodRx Holdings (GDRX)
$2.85+0.05 (+1.79%)
Market ClosedLast close Jun 29
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
GoodRx Holdings, Inc. in the Healthcare sector is trading at $2.85 with a market capitalization of $916M. Wall Street consensus targets $3.18 (13 analysts), implying a +11.6% move over the next 12 months. The stock is currently 51% below its 52-week high of $5.81, remaining 0.7% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +11.6% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $194.01M↓ | $194.78M↓ | $196.03M↓ | $203.07M | $202.97M |
| Gross Profit | $173.85M↓ | $177.32M↓ | $182.61M↓ | $189.72M | $189.61M |
| Operating Income | $14.01M↓ | $22.68M↑ | $14.62M↓ | $26.81M↑ | $23.38M |
| Net Income | $1.17M↓ | $5.42M↑ | $1.12M↓ | $12.84M↑ | $11.05M |
Peer Comparison
JNJUNHPFE
Fundamentals
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that prov...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$916.12M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
3.30%
Volume
Today's trading volume
1.24M
Recent News
2 Healthcare Stocks to Consider Right Now and 1 We Brush Off
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six months, healthcare stocks have gained 7.6%, nearly mirroring the S&P 500.
Biodesix (BDSX) Surges 10.5%: Is This an Indication of Further Gains?
Biodesix (BDSX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Q1 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology industry, including GoodRx (NASDAQ:GDRX) and its peers.
1 Stock Under $10 to Target This Week and 2 We Find Risky
Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as many have questionable fundamentals.
Billionaire Mark Cuban Says America’s Drug Pricing System Makes Patients Pay the Highest Price, ‘Make It Make Sense. It Doesn’t.’
In Senate testimony, Cuban compared pharmacy benefit managers to Amazon’s control over online sellers, arguing that PBMs use their power over formularies to keep list prices high while patients, employers, pharmacies, and taxpayers absorb the damage.